Trials / Completed
CompletedNCT03290547
Pilot Study of Multi-wavelength Laser for Tattoo Removal
A Multi-Center Pilot Study of a Novel Multi-Wavelength Laser for Tattoo Removal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Cutera Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and efficacy of an investigational version of the Cutera enLighten laser that offers muliple wavelengths for tattoo removal.
Detailed description
Currently, the enLighten laser offers two wavelengths: 532nm and 1064nm. The version of the laser under investigation allows the user to choose a wavelength between 640nm to 800nm. This is a multi-center prospective, open-label, uncontrolled pilot study in up to 75 male or female subjects, age 18 to 65 years, who desire laser removal of a tattoo containing single or multi-color ink. Subjects will receive laser treatments and will be followed at 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cutera enLighten laser | Subjects will receive laser treatments. |
Timeline
- Start date
- 2015-07-08
- Primary completion
- 2017-11-29
- Completion
- 2017-11-29
- First posted
- 2017-09-25
- Last updated
- 2023-09-15
- Results posted
- 2023-09-15
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03290547. Inclusion in this directory is not an endorsement.